Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -23.64x is 53% below its 4-year average of -15.50x, near the high end of its 4-year range (-39122.16x–-2.46x).
As of the fiscal period ended Thursday, June 30, 2022. 7.24% below its 12-month average of -22.04x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2022 (2022-06-30): -23.64x.
INTEREST COVERAGE RATIO
-23.64x
INTEREST COVERAGE RATIO AVG TTM
-22.04x
INTEREST COVERAGE RATIO AVG 3Y
-64.22x
INTEREST COVERAGE RATIO AVG 5Y
-15.50x
INTEREST COVERAGE RATIO AVG 10Y
-1018.20x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-7.24%
CURRENT VS 3Y AVG
+63.19%
CURRENT VS 5Y AVG
-52.53%
CURRENT VS 10Y AVG
+97.68%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-270.79%
vs the sector median at left
Rezolute, Inc.
Market Cap
$404.30M
Interest Coverage Ratio
-23.64x
TTM Avg
-22.04x
3Y Avg
-64.22x
5Y Avg
-15.50x
Market Cap
$404.94M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$402.01M
Interest Coverage Ratio
-20641.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$405.49M
Interest Coverage Ratio
-6.46x
TTM Avg
19.36x
3Y Avg
139.34x
5Y Avg
245.68x
Market Cap
$401.25M
Interest Coverage Ratio
-21.38x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$409.29M
Interest Coverage Ratio
-404.95x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$410.03M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$398.17M
Interest Coverage Ratio
-375.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$412.91M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rezolute, Inc. (RZLT) | $404.30M | -23.64x | -22.04x | -64.22x | -15.50x |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $404.94M | N/A | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $402.01M | -20641.60x | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $405.49M | -6.46x | 19.36x | 139.34x | 245.68x |
| Carlsmed, Inc. (CARL)vs › | $401.25M | -21.38x | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $409.29M | -404.95x | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $410.03M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $398.17M | -375.67x | N/A | N/A | N/A |
| MapLight Therapeutics, Inc. (MPLT)vs › | $412.91M | N/A | N/A | N/A | N/A |
| Prothena Corporation plc (PRTA)vs › | $418.30M | N/A | N/A | N/A | N/A |
Interest Coverage
-23.6x
Debt/Equity
0.01
Current Ratio
9.44
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-06-30 | -23.64x |
| 2022-03-31 | -24.33x |
| 2021-12-31 | -27.30x |
| 2021-09-30 | -17.25x |
| 2021-06-30 | -17.70x |
| 2019-06-30 | -275.08x |
| 2019-03-31 | -6.20x |
| 2018-12-31 | -2.46x |
| 2018-09-30 | -2.81x |
| 2018-06-30 | -17.80x |
| 2018-03-31 | -92.83x |
| 2017-12-31 | -39122.16x |
| 2016-09-30 | -2397.29x |
| 2016-06-30 | -4280.62x |
| 2016-03-31 | -3250.63x |
| 2015-12-31 | -2948.90x |
| 2015-09-30 | -2045.69x |
| 2015-06-30 | -1677.62x |
| 2015-03-31 | -1102.68x |
| 2014-12-31 | -1334.94x |
| 2014-09-30 | -4470.24x |
| 2014-06-30 | -4459.43x |
| 2014-03-31 | -0.46x |
| 2013-12-31 | -1.04x |
| 2013-09-30 | -4.25x |
| 2013-06-30 | -5.87x |
| 2013-03-31 | -22.31x |
| 2012-12-31 | -0.25x |
| 2012-09-30 | -0.11x |
| 2012-03-31 | -0.11x |
